ThinkCyte
thinkcyte.com
Actively hiring
Laboratory Equipment
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$32M
1 round on record
Latest round
$32M
Series C · Aug 2024 · 2 yr ago
Team
201-500
employees, estimated range
Backers
1
Global Brain
The money's age
Long since its last round
25 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 3, 2025
Launched ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis · YahooFinance
Aug 30, 2024
Raised a round Series C $32M · menafn
Jul 2016
Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series C | Aug 2024 | $32M | — | menafn |
Backed byfrom the funds' portfolios and accelerator catalogs
Global Brain Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
CellChorus conducts dynamic single-cell analysis at scale. Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) uses visual AI to…
ONI offers innovative super-resolution microscopy systems including Aplo Scope, Nanoimager, and Aplo Flow. Explore dSTORM, PALM, DNA-PAINT…
Ramona builds the world's fastest live-cell and small-organism imaging systems. Image a full 96-well plate in under 2 minutes with…
The world’s first All-in-One intravital microscopy platform from IVIM Technology is a key solution that can explore complex dynamic…
BrightSpec commercializes MRR spectroscopy instruments for definitive molecular structure identification and quantitation.
Join ABio-X: life sciences incubator driving novel drug discovery and company formation to address large, daunting diseases.
Overview
ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support life-science research, diagnostics and therapeutics. It commercializes Ghost Cytometry, a high-throughput fluorescence image-based cell-sorting platform that enables rapid, image-informed sorting and characterization of cells. The company targets research institutions, diagnostic developers and cell-therapy manufacturers seeking high-speed, image-based cytometry and sorting solutions.
News
ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis
ThinkCyte, a life science company pioneering advanced AI-powered cell analysis and sorting technologies, today announced the pre-commercial launch of MorphoScan Cloud, its new cloud-based platform designed for flexible data access, faster processing, and
Read more
Report
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyte. The announcement coin
Read more
Report
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
Read more
Report
Thinkcyte Secures $32 Million In Series C Funding To Drive Global Expansion Of Visionsorttm
Thinkcyte Secures $32 Million In Series C Funding To Drive Global Expansion Of Visionsorttm.TOKYO and REDWOOD CITY, Calif., Aug. 30, 2024 /PRNewswire/ -- ThinkCyte today announced the successful completion of its Series C funding round. Including the equi
Read more
Report
Toyoda Gosei Invests in ThinkCyte, a Startup Developing Devices for the Early Detection of Leukemia and Other Diseases
Read more
Report
ThinkCyte and FIMM Establish Research Partnership to Advance Understanding and Treatment of Blood Cancer
Read more
Report
ThinkCyte, Inc.: Machine vision-based cell sorting transforms cell therapy and drug discovery
Combining cell sorting technology with artificial intelligence, Japan-based ThinkCyte aims to discover novel high-value therapeutic cells, new functional genes, and novel drug candidates for itself and its partners worldwide.
Read more
Report
Hitachi and ThinkCyte announce collaboration to develop an AI-driven cell analysis and sorting system
--Hitachi, Ltd. and ThinkCyte, Inc. today announced that they have entered into a collaboration focused on developing an artificial intelligence- driven cell analysis and sorting system. The practical applications of regenerative medicine and cell therapy
Read more
Report
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
0
Countries
2
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
San Carlos
United States
HQ
CONTACT US
1030 Brittan Avenue San Carlos,, CA 94070 USA
Minoh
Japan
Regional office
Japan
Minoh Senri Bldg. 6F, 3-4-17 Senbahigashi, Minoh-shi,Osaka, 562-0035, Japan, +81-72-730-6790
Belgium
United States
Regional office
Belgium, Netherlands, Luxembourg
Preston
United States
Regional office
AUSTRALIA
Financials
Total raised
$32M
Latest round
Series C
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series C | 2024 | $32M | Details |